Predictors of Mortality in Sarcoidosis
Clinics in Chest Medicine · 2024
DOI: 10.1016/j.ccm.2023.06.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Chest Medicine, 2024. Verfasst von Gamze Kırkıl. Beteiligte Einrichtung: Medicine Faculty, Department of Chest Disease, Firat University, Elazig 23200, Turkey. Electronic address: gamkirkil@yahoo.com. Hauptthemen laut MEDLINE: Sarcoidosis, Pulmonary Fibrosis, Hypertension, Pulmonary, Respiratory Insufficiency. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
Sarcoidosis is a systemic granulomatous disorder that affects individuals of all racial/ethnic origins and occurs at any time of life. Spontaneous remission is frequent and may occur in 2 of 3 patients, while the remaining cases have chronic, progressive disease, with some patients presenting with organ- and life-threatening involvements. Many reports have investigated which features may be related to poor outcomes in patients with sarcoidosis. Pulmonary hypertension and respiratory failure from pulmonary fibrosis are the most common complications associated with the cause of death in sarcoidosis. Other major causes of death include cardiac, neurologic, hepatic involvement, and hemoptysis from aspergilloma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine Faculty, Department of Chest Disease, Firat University, Elazig 23200, Turkey. Electronic address: gamkirkil@yahoo.com.
Zitieren
APA
Kırkıl, G. (2024). Predictors of Mortality in Sarcoidosis. Clinics in Chest Medicine. https://doi.org/10.1016/j.ccm.2023.06.006
Vancouver
Kırkıl G. Predictors of Mortality in Sarcoidosis. Clinics in Chest Medicine. 2024. doi:10.1016/j.ccm.2023.06.006
BibTeX
@article{Krkl2024,
author = {Kırkıl, Gamze},
title = {Predictors of Mortality in Sarcoidosis},
journal = {Clinics in Chest Medicine},
year = {2024},
doi = {10.1016/j.ccm.2023.06.006}
}
EUVIMED